Celgene (CELG) Tops Q1 EPS by 1c

Go back to Celgene (CELG) Tops Q1 EPS by 1c

Celgene (CELG) Q1 'Strong' in Seasonally Weak Quarter, BMO Capital Says

April 30, 2015 2:57 PM EDT

BMO Capital analyst Jim Birchenough reiterated his Outperform rating and $163 price target on Celgene (NASDAQ: CELG) following Q1 result which he called "solid" despite seasonal headwinds.

Birchenough commented, "We are reiterating our Outperform rating on the shares of CELG following review of 1Q15... More